Prognostic value of plasma D-dimer levels in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: a retrospective study

BACKGROUND: Plasma D-dimer is of great significance for the clinical exclusion of tumor-related thrombosis. Previous studies have shown its predictive role in non-small cell lung cancer (NSCLC) treated with chemotherapy. However, whether pretreatment D-dimer could predict the efficacy and prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoyan, Lu, Di, Zhang, Zhibo, Zhang, Yuning, Wang, Jinliang, Hu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641356/
https://www.ncbi.nlm.nih.gov/pubmed/36389301
http://dx.doi.org/10.21037/jtd-22-1363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641356/
https://www.ncbi.nlm.nih.gov/pubmed/36389301
http://dx.doi.org/10.21037/jtd-22-1363

Ejemplares similares